How Is Boeing’s Stock Performance Compared to Other Aerospace & Defense Stocks

Photo of author

By Ronald Tech

Valued at a market cap of $96.8 billion, The Boeing Company (BA) designs, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services. The Arlington, Virginia-based company’s customers include domestic & foreign airlines, the U.S. Department of Defense, NASA, other aerospace prime contractors, and certain U.S. government and commercial communications customers.

Companies valued at over $10 billion are typically classified as “large-cap stocks,” and The Boeing Company fits the label perfectly. As a leading global aerospace company, it serves customers in more than 150 countries and continues to expand its product line and services to meet emerging customer needs.

Despite its strengths, the aircraft manufacturer’s shares have slipped 42.1% from its 52-week high of $267.54 reached on Dec. 21, 2023. Moreover, over the past three months, BA declined 3.7%, significantly lagging behind the SPDR S&P Aerospace & Defense ETF’s (XAR) 14.1% gain. 

www.barchart.com

Moreover, in the longer term, BA has declined 33.7% over the past 52 weeks, significantly underperforming XAR’s 32.2% returns. On a YTD basis, shares of BA are down 40.5%, massively lagging behind XAR’s 27.1% gains over the same time frame.

To confirm its bearish price trend, BA has been trading below its 200-day moving average since late January. However, the stock has been trading above its 50-day moving average since late November. 

www.barchart.com

The primary causes of BA’s poor performance over the past year are the company’s quality control problems with its 787-jet model, which necessitated rework, and a slowdown in its 737-production rate due to inspections following the Alaska Airlines incident. Another significant blow to Boeing’s operational performance was the seven-week labor strike, which ended on Nov. 4. These factors negatively impacted the company’s recent Q3 performance as well. 

See also  Defensive Dividend Stocks Offering Stability Amid Pre-Election VolatilityExploring Zoetis - A Defensive Dividend Stock

As the U.S. presidential election fast approaches, investor anxieties are reaching a fever pitch like an orchestra building up to a crescendo. In such times of market tumult, seeking refuge in defensive dividend stocks can be akin to finding a sturdy lifeboat in a stormy sea.

The Resilient Rise of Zoetis

Among the entities that stand out in this defensive arena is Zoetis Inc., a stalwart player in the realm of animal health. With a legacy spanning over seven decades, Zoetis has become a beacon of stability in a sea of market fickleness, akin to a lighthouse guiding ships through rough waters.

A Fortified Fortress

Despite a YTD dip of 4%, Zoetis has clung tenaciously to its pillars of stability amidst the tumultuous market winds. The company's market cap looms large at around $85.1 billion, offering an anchor of steadfastness when the market tides turn rough.

A Flourishing Haven

Zoetis' five-year streak of consecutive dividend increases speaks volumes about its resilience. The company sails ahead, paying out a quarterly dividend of $0.432 per share with an annualized dividend of $1.73 per share.

Visionary Leadership and Financial Prowess

In August, Zoetis made waves as it surpassed all expectations with its second-quarter earnings. Like an eagle soaring high above the clouds, the company posted a revenue of $2.4 billion, signaling an 8% rise from the previous year—a testament to its unyielding spirit in the face of adversity.

The Bright Horizon

Guided by CEO Kristin Peck's steady hand, Zoetis raised its fiscal 2024 guidance with the confidence of a sure-footed mountaineer conquering new heights. The company anticipates revenue growth between $9.10 billion and $9.25 billion, paving the way for a brighter future.

The Astounding Acclaim and Future Projections

With a resounding consensus of "Strong Buy" ratings from analysts, Zoetis stands as a paragon of excellence in the eyes of the market. The price targets put forth a promising future, with a potential upside of 15.7% from current levels.

Diving into Kenvue - A Shield Against Turbulence

Turning our gaze to another bastion of stability, Kenvue Inc. emerges as a formidable contender in the landscape of consumer health, a shield repelling the arrows of uncertain market forces.

The Sturdy Bulwark

With a rich heritage dating back over a century, Kenvue boasts a diversified portfolio of trusted brands, standing strong with a market cap of $43.1 billion. The stock has surged 23% in the past three months, outshining broader market indices like a gleaming beacon in the night sky.

Ensuring Growth and Stability

Kenvue's recent dividend increase underscores its unwavering commitment to shareholders, offering $0.205 per share and a hearty 3.64% yield. This move aligns with the company's endeavor to drive sustainable growth and provide a steady hand amid market turmoil.

Financial News: Unlocking the Performance of Kenvue and American Water Works Unlocking the Performance of Kenvue and American Water Works

Moreover, on Oct. 23, BA’s shares plunged 1.8% following its Q3 earnings release. The company’s revenue fell 1.4% year-over-year to $17.84 billion and came in line with Wall Street’s forecasted figure. However, its adjusted loss widened significantly by 220.2%, totaling $10.44 per share, and missed the consensus estimates of a loss of $10.34 per share. 

BA’s underperformance becomes even more evident when compared to its rival, Lockheed Martin Corporation (LMT), which gained 15% over the past 52 weeks and 14.1% on a YTD basis. 

Despite BA’s underwhelming price action so far, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 24 analysts covering it, and the mean price target of $187.25 suggests a 20.8% premium to its current levels. 


On the date of publication,

Neharika Jain

did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy

here.
More news from Barchart